China Pharma Holdings, Inc.  

(Public, NYSEAMEX:CPHI)   Watch this stock  
Find more results for CPHI
0.355
-0.005 (-1.39%)
Real-time:   11:26AM EDT
NYSEAMEX real-time data - Disclaimer
Currency in USD
Range 0.35 - 0.37
52 week 0.21 - 2.43
Open 0.37
Vol / Avg. 6,900.00/30,318.00
Mkt cap 15.45M
P/E 0.91
Div/yield     -
EPS 0.39
Shares 43.53M
Beta 1.35
Inst. own 23%
May 15, 2012
Q1 2012 China Pharma Holdings, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 17.45% 23.74%
Operating margin 21.22% 26.76%
EBITD margin - 28.21%
Return on average assets 7.03% 13.38%
Return on average equity 7.80% 14.80%
Employees 435 -
Carbon Disclosure Rating - -

Address

Second Floor, No. 17 Jinpan Road
HAIKOU, HAN 570216
China
+86-898-66811730 (Phone)
+86-898-66819024 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

China Pharma Holdings, Inc. owns 100% of Onny Investment Limited (Onny) and Hainan Helpson Medical & Biotechnology Co., Ltd (Helpson). The Company�s portfolio includes products for treatment of central nervous system diseases, cerebral and cardio vascular disorders, infectious diseases and respiratory and digestive illnesses. Through Helpson, the Company manufactures and markets generic and branded pharmaceutical products primarily to hospitals and private retailers located throughout the People�s Republic of China (PRC). Helpson also manufactures biochemical products, health products and cosmetics. As of December 31, 2009, China Pharma Holdings, Inc. was manufacturing or ready to manufacture a total of 20 pharmaceutical products.

Officers and directors

Zhilin Li Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation - Reuters
Frank Waung Chief Financial Officer
Age: 46
Bio & Compensation - Reuters
Heung Mei Tsui Director
Age: 54
Bio & Compensation - Reuters
Gene Michael Bennett Independent Director
Age: 64
Bio & Compensation - Reuters
Baowen Dong Independent Director
Age: 70
Bio & Compensation - Reuters
Yingwen Zhang Independent Director
Age: 67
Bio & Compensation - Reuters